Gut microbiome alterations in preclinical Alzheimer’s disease
<h4>Background</h4> Although some human studies have reported gut microbiome changes in individuals with Alzheimer’s disease (AD) dementia or mild cognitive impairment (MCI), gut microbiome alterations in preclinical AD, i.e., cerebral amyloidosis without cognitive impairment, is largely...
Main Authors: | Joon Hyung Jung, Gihyeon Kim, Min Soo Byun, Jun Ho Lee, Dahyun Yi, Hansoo Park, Dong Young Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707757/?tool=EBI |
Similar Items
-
Gut microbiome alterations in preclinical Alzheimer's disease.
by: Joon Hyung Jung, et al.
Published: (2022-01-01) -
Early-Life Cognitive Activity Is Related to Reduced Neurodegeneration in Alzheimer Signature Regions in Late Life
by: Kang Ko, et al.
Published: (2018-03-01) -
Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer’s Disease
by: Valeria D’Argenio, et al.
Published: (2022-08-01) -
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
by: Hyo Jung Choi, et al.
Published: (2017-08-01) -
Contributions of the microbiome to intestinal inflammation in a gut-on-a-chip
by: Min Seo Jeon, et al.
Published: (2022-02-01)